Close Menu
  • DRUGS
  • DISEASES
  • Treatments
  • Wellness

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Hemangiopericytoma

Cancer

Thymoma

Cancer

Squamous Cell Carcinoma

Cancer
Facebook X (Twitter)
GoodMedTodayGoodMedToday
  • Demos
  • Health
  • Covid19
  • About Us
Facebook X (Twitter)
SUBSCRIBE
  • DRUGS
  • DISEASES
  • Treatments
  • Wellness
GoodMedTodayGoodMedToday
Home - O - Ofloxacin
O

Ofloxacin

Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

Comprehensive Guide to Ofloxacin: Uses, Dosage, Side Effects, and More

Table of Contents

Toggle
  • What is Ofloxacin?
  • Overview of Ofloxacin
  • Indications and Uses of Ofloxacin
  • Dosage of Ofloxacin
  • How to Use Ofloxacin
  • Contraindications for Ofloxacin
  • Side Effects of Ofloxacin
  • Warnings & Precautions for Ofloxacin
  • Overdose and Management of Ofloxacin
  • Drug Interactions with Ofloxacin
  • Patient Education or Lifestyle
  • Pharmacokinetics of Ofloxacin
  • Pharmacodynamics of Ofloxacin
  • Storage of Ofloxacin
  • Frequently Asked Questions (FAQs)
  • Regulatory Information
  • References

What is Ofloxacin?

Ofloxacin is a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and bacterial growth. This medication is widely used to treat a variety of bacterial infections, offering effective therapy across multiple body systems.

Overview of Ofloxacin

Generic Name: Ofloxacin

Brand Name: Floxin, generics

Drug Group: Fluoroquinolone (antibiotic)

Commonly Used For

  • Treat bacterial infections.
  • Manage urinary tract infections (UTIs).
  • Address respiratory tract infections.

Key Characteristics

Form: Oral tablets (200 mg, 300 mg, 400 mg), ophthalmic solution (0.3%), otic solution (0.3%) (detailed in Dosage section).

Mechanism: Inhibits bacterial DNA replication, targeting Gram-negative and Gram-positive bacteria.

Approval: FDA-approved (1990 for Floxin) and EMA-approved for various infections.

A box and a bottle of Bausch + Lomb Ofloxacin Otic Solution, 0.3% (Sterile), for use in ears only.
Ofloxacin Otic Solution is an antibiotic ear drop used to treat ear infections.

Indications and Uses of Ofloxacin

Ofloxacin is indicated for a wide range of bacterial infections, leveraging its broad-spectrum activity:

Urinary Tract Infections (UTIs): Treats uncomplicated and complicated UTIs caused by E. coli, Klebsiella, and Proteus, reducing symptoms like dysuria, per urology guidelines.

Prostatitis: Manages acute and chronic bacterial prostatitis, improving urinary flow and reducing inflammation, supported by infectious disease studies.

Pneumonia: Treats community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae and Haemophilus influenzae, enhancing respiratory recovery.

Chronic Bronchitis: Controls acute exacerbations of chronic bronchitis due to susceptible bacteria, improving lung function, per pulmonology protocols.

Skin and Soft Tissue Infections: Addresses cellulitis and wound infections caused by Staphylococcus aureus, promoting wound healing.

Sexually Transmitted Infections (STIs): Used off-label for chlamydia and gonorrhea (e.g., Neisseria gonorrhoeae), though resistance is rising, with data from sexual health research.

Ophthalmic Infections: Treats bacterial conjunctivitis and corneal ulcers with 0.3% ophthalmic drops, reducing ocular inflammation, supported by ophthalmology trials.

Otitis Externa: Manages acute otitis externa (swimmer’s ear) with 0.3% otic solution, alleviating ear pain, per ENT guidelines.

Bone and Joint Infections: Investigated off-label for osteomyelitis and septic arthritis caused by susceptible pathogens, improving joint function, with orthopedic evidence.

Traveler’s Diarrhea: Employed off-label for severe cases due to Campylobacter or Shigella, reducing diarrhea duration, supported by travel medicine studies.

Intra-Abdominal Infections: Explored off-label in combination therapy for complicated intra-abdominal infections, enhancing recovery, with surgical infectious disease data.

Note: This drug is for bacterial infections only; consult a healthcare provider for resistance testing or alternative therapy if symptoms persist.

Dosage of Ofloxacin

Important Note: The dosage of this fluoroquinolone must be prescribed by a healthcare provider. Dosing varies by infection type, severity, and patient factors, with adjustments based on clinical evaluation.

Dosage for Adults

Urinary Tract Infections (UTIs):

  • Uncomplicated: 200–400 mg orally every 12 hours for 3–7 days.
  • Complicated: 400 mg every 12 hours for 7–14 days.

Prostatitis: 300 mg orally every 12 hours for 6 weeks (chronic) or 2–4 weeks (acute).

Pneumonia or Bronchitis: 400 mg orally every 12 hours for 7–14 days.

Skin and Soft Tissue Infections: 400 mg every 12 hours for 7–10 days.

Ophthalmic (0.3% Solution): 1–2 drops in affected eye every 2–4 hours for 2 days, then 4 times daily for 5 days.

Otic (0.3% Solution): 10 drops in affected ear twice daily for 7 days.

Dosage for Children

Not recommended under 18 years except for specific cases (e.g., complicated UTIs) under pediatric infectious disease supervision:

  • 7.5–15 mg/kg orally every 12 hours for 7–14 days, maximum 400 mg/dose.
  • Ophthalmic/otic use may be considered with caution.

Dosage for Pregnant Women

Pregnancy Category C: Avoid unless benefits outweigh risks (e.g., severe infection). Consult an obstetrician, with fetal monitoring.

Dosage Adjustments

Renal Impairment: Reduce dose if CrCl <50 mL/min (e.g., 200 mg every 24 hours if CrCl 10–50 mL/min; avoid if <10 mL/min).

Hepatic Impairment: No adjustment needed; monitor in severe cases (Child-Pugh C).

Elderly: Start with 200 mg every 12 hours; increase cautiously to 400 mg if tolerated.

Concomitant Medications: Adjust if combined with NSAIDs or corticosteroids, increasing tendon rupture risk.

Additional Considerations

  • Take this active ingredient with a full glass of water, with or without food, avoiding dairy or antacids (delay 2 hours).
  • Complete the full course to prevent resistance.

How to Use Ofloxacin

Administration:

  • Swallow tablets whole with water, avoiding dairy, calcium, or iron supplements within 2 hours.
  • Apply ophthalmic/otic solutions as directed, avoiding contact lens use during treatment.
  • Administer injections (if available) via IV over 60 minutes in a clinical setting.

Timing: Use every 12 hours, maintaining consistency (e.g., morning and evening).

Monitoring: Watch for tendon pain, rash, or signs of allergic reaction (e.g., swelling).

Additional Tips:

  • Store tablets at 20–25°C (68–77°F), ophthalmic/otic solutions at 15–30°C (59–86°F), protecting from light.
  • Keep out of reach of children due to toxicity risk.
  • Report severe joint pain, difficulty breathing, or signs of nerve damage immediately.

Contraindications for Ofloxacin

Hypersensitivity: Patients with a known allergy to Ofloxacin, other fluoroquinolones, or quinolones.

Tendon Disorders: Contraindicated in patients with a history of tendon rupture or myasthenia gravis.

QT Prolongation: Avoid in patients with known QT prolongation or uncorrected hypokalemia.

Side Effects of Ofloxacin

Common Side Effects

  • Nausea (5–10%, manageable with food)
  • Diarrhea (4–8%, transient)
  • Headache (3–7%, relieved with rest)
  • Insomnia (2–6%, decreases with tolerance)
  • Dizziness (2–5%, avoid driving)

These effects may subside with dose adjustment.

Serious Side Effects

Seek immediate medical attention for:

  • Musculoskeletal: Tendon rupture, arthralgia, or myalgia.
  • Neurological: Peripheral neuropathy or seizures.
  • Cardiac: QT prolongation or torsades de pointes.
  • Allergic: Rash, Stevens-Johnson syndrome, or anaphylaxis.
  • Renal: Acute kidney injury or crystalluria.

Additional Notes

  • Regular monitoring for tendon health, kidney function, and heart rhythm is advised.
  • Report any unusual symptoms (e.g., joint swelling, vision changes) immediately to a healthcare provider.

Warnings & Precautions for Ofloxacin

General Warnings

Tendon Rupture: Risk of Achilles or other tendon rupture, especially in elderly or steroid users; discontinue if pain occurs.

Peripheral Neuropathy: Risk of nerve damage; stop if numbness or weakness develops.

QT Prolongation: Risk of arrhythmias; avoid in patients with heart conditions.

Clostridium difficile Infection: Risk of severe diarrhea; monitor for colitis.

Hypersensitivity Reactions: Risk of anaphylaxis; discontinue if severe.

Additional Warnings

Central Nervous System Effects: May cause dizziness or seizures; avoid driving if affected.

Photosensitivity: Increased skin reaction to sunlight; use sunscreen.

Aortic Aneurysm: Rare risk of dissection; screen high-risk patients.

Hypoglycemia: Risk in diabetic patients on oral hypoglycemics; monitor glucose.

Renal Impairment: Monitor in severe cases; adjust dose if needed.

Use in Specific Populations

Pregnancy: Category C; avoid unless critical; use alternatives if possible.

Breastfeeding: Excreted in breast milk; monitor infant for effects.

Elderly: Higher risk of tendon rupture; start with lower doses.

Children: Avoid under 18 years unless essential; supervise closely.

Renal/Hepatic Impairment: Adjust dose; avoid in severe cases.

Additional Precautions

  • Inform your doctor about tendon issues, heart disease, or medication history before starting this medication.
  • Avoid abrupt cessation; complete the prescribed course.

Overdose and Management of Ofloxacin

Overdose Symptoms

  • Nausea, vomiting, or dizziness.
  • Severe cases: Seizures, renal failure, or QT prolongation.
  • Confusion, tremor, or headache as early signs.
  • Cardiac arrest with extremely high doses.

Immediate Actions

Contact the Medical Team: Seek immediate medical help.

Supportive Care: Administer activated charcoal if ingested recently, monitor vital signs, and provide IV fluids.

Specific Treatment: Manage seizures with benzodiazepines, correct electrolytes, and monitor ECG; no specific antidote.

Monitor: Check kidney function, heart rhythm, and mental status for 24–48 hours.

Additional Notes

  • Overdose risk is low; store securely.
  • Report persistent symptoms (e.g., irregular heartbeat, severe weakness) promptly.

Drug Interactions with Ofloxacin

This active ingredient may interact with:

  • NSAIDs/Corticosteroids: Increases tendon rupture risk; use cautiously.
  • Anticoagulants: Enhances bleeding risk (e.g., warfarin); monitor INR.
  • Antiarrhythmics: Potentiates QT prolongation (e.g., amiodarone); avoid.
  • Antidiabetics: Alters glucose levels; monitor blood sugar.
  • Iron/Calcium Supplements: Reduces absorption; separate by 2 hours.

Action: Provide your healthcare provider with a complete list of medications.

Patient Education or Lifestyle

Medication Adherence: Take this fluoroquinolone as prescribed to manage infections, completing the full course.

Monitoring: Report tendon pain, rash, or dizziness immediately.

Lifestyle: Avoid sun exposure; use protective clothing and sunscreen.

Diet: Take with water, avoiding dairy or antacids; maintain hydration.

Emergency Awareness: Know signs of tendon rupture or allergic reaction; seek care if present.

Follow-Up: Schedule regular check-ups every 1–2 weeks during therapy to monitor kidney and tendon health.

Pharmacokinetics of Ofloxacin

Absorption: Well-absorbed orally (peak at 1–2 hours); reduced by food or divalent cations.

Distribution: Volume of distribution ~1.2–1.5 L/kg; 20–40% protein-bound.

Metabolism: Minimal hepatic metabolism; excreted largely unchanged.

Excretion: Primarily renal (80–90%) as unchanged drug; half-life 5–7 hours.

Half-Life: 5–7 hours, with prolonged effects in renal impairment.

Pharmacodynamics of Ofloxacin

This drug exerts its effects by:

  • Inhibiting DNA gyrase and topoisomerase IV, halting bacterial DNA replication.
  • Exhibiting bactericidal activity against Gram-negative and Gram-positive pathogens.
  • Demonstrating dose-dependent risks of tendon damage and QT prolongation.
  • Showing enhanced efficacy in combination with other antibiotics for resistant strains.

Storage of Ofloxacin

Temperature: Store tablets at 20–25°C (68–77°F), ophthalmic/otic solutions at 15–30°C (59–86°F); protect from light.

Protection: Keep in original container, away from moisture.

Safety: Store in a locked container out of reach of children due to toxicity risk.

Disposal: Dispose of unused tablets or solutions per local regulations or consult a pharmacist.

Frequently Asked Questions (FAQs)

Q: What does Ofloxacin treat?
A: This medication treats bacterial infections like UTIs and pneumonia.

Q: Can this active ingredient cause tendon issues?
A: Yes, tendon rupture may occur; stop if pain develops.

Q: Is Ofloxacin safe for children?
A: Generally avoided under 18 years unless critical; consult a doctor.

Q: How is this drug taken?
A: Orally as tablets or as drops (eye/ear), as directed.

Q: How long is Ofloxacin treatment?
A: 3–14 days, depending on infection severity.

Q: Can I use Ofloxacin if pregnant?
A: No, avoid unless essential; consult a doctor.

Regulatory Information

This medication is approved by:

U.S. Food and Drug Administration (FDA): Approved in 1990 (Floxin) for various infections.

European Medicines Agency (EMA): Approved for bacterial infections.

Other Agencies: Approved globally for infectious diseases; consult local guidelines.

References

  1. U.S. Food and Drug Administration (FDA). (2023). Floxin (Ofloxacin) Prescribing Information.
    • Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
  2. European Medicines Agency (EMA). (2023). Ofloxacin Summary of Product Characteristics.
    • EMA’s comprehensive information on the medication’s indications and precautions in Europe.
  3. National Institutes of Health (NIH). (2023). Ofloxacin: MedlinePlus Drug Information.
    • NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
  4. World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Ofloxacin.
    • WHO’s inclusion of Ofloxacin for bacterial infections.
  5. Journal of Antimicrobial Chemotherapy. (2022). Ofloxacin in Resistant Infections.
    • Peer-reviewed article on Ofloxacin efficacy (note: access may require a subscription).
Disclaimer: This article provides general information about Ofloxacin for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider, such as an infectious disease specialist or primary care physician, before using this drug or making any medical decisions. Improper use of this active ingredient can lead to serious health risks, including tendon rupture or severe allergic reactions.
Previous ArticleOctreotide
Next Article Olanzapine
Andrew Parker, MD
  • Website

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts

Vericiguat

September 14, 2025

Verteporfin

September 14, 2025

Vibegron

September 14, 2025
Don't Miss
Cancer

Hemangiopericytoma

Perivascular Cell Tumor: Causes, Symptoms, and Treatment Perivascular cell tumors are a type of soft…

Thymoma

Cancer

Squamous Cell Carcinoma

Cancer

Chondrosarcom

Cancer
Our Picks

Hemangiopericytoma

Cancer

Thymoma

Cancer

Squamous Cell Carcinoma

Cancer

Chondrosarcom

Cancer
About Us
About Us

GoodMedToday is a global health blog providing trustworthy, reader-friendly information on diseases, medications, healthy living, and medical therapies. We help you make informed health decisions with content based on reputable medical sources.

Contact Us: contact@goodmedtoday.com
Contact: +1-320-0123-451

Our Picks
New Comments

    Type above and press Enter to search. Press Esc to cancel.